Alzheimer's

Rosanne Corcoran (right) had to provide all of the hands-on care her mother Rose Carfagno (left) needed when she developed dementia. Corcoran is one of nearly 7 million people in the U.S. who care for loved ones living Alzheimer's and other dementia diseases.

Health

How supporting caregivers could make a difference in dementia

Patients and their caregivers are often left to navigate the confusing world of dementia by themselves, but Medicare is launching a new program to change that.

This image provided by Eli Lilly shows the company's new Alzheimer’s drug Kisunla. The Food and Drug Administration approved Eli Lilly’s Kisunla on Tuesday for mild or early cases of dementia caused by Alzheimer’s.

Health

FDA approves a second Alzheimer's drug that can modestly slow disease

The Associated Press

The approval of Eli Lilly's Kisunla provides a new option for patients in the early stages of the incurable, memory-destroying ailment.

A large study of an experimental Alzheimer's drug made by pharmaceutical company Eli Lilly & Co. appears to slow worsening of the degenerative brain disease.

Health

An experimental Alzheimer's drug outperforms one just approved by the FDA

In a large study, the experimental drug donanemab slowed the progression of Alzheimer's by about 35%. That's slightly better than the drug Leqembi, which was fully approved by the FDA on July 6.